Abizer Gaslightwala - CEO, Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type: Individual
Role: CEO, Director
Issuer Symbol: AKTX on Nasdaq
All Insider Reports: All Insider Reports

Abizer Gaslightwala - trading volume in the past year for Akari Therapeutics Plc

	Shares	%	Avg Price	Total $
Buys	+1,134,797	100%	$0.4355	+$494,159
Sells
Net	+1,134,797	100%		+$494,159

Holdings reported by Abizer Gaslightwala for Akari Therapeutics Plc

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Pre-Funded Warrants to purchase ADRs	773,323	$312,499	$0.4041	16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
American Depositary Shares representing Ordinary Shares	298,574	$268,716	$0.9000	25 Aug 2025	Direct
Series A Warrants (Right to Buy)	133,928	$149,999	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
Series B Warrants (Right to Buy)	133,928	$149,999	$1.12	06 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
American Depository Shares representing Ordinary Shares	47,500	$57,950	$1.22	10 Jan 2025	Direct
Ordinary Shares, par value $0.0001 per share	71,720,000	$43,032	$0.000600	03 Jan 2025	Direct
Warrants to purchase ADRs	773,323			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares
Stock Option (Right to Buy)	600,000			20 Mar 2025	Direct	American Depositary Shares representing Ordinary Shares
Warrants to purchase American Depositary Shares ("ADRs")	309,328			16 Dec 2025	Direct	American Depositary Shares representing Ordinary Shares

Transactions reported by Abizer Gaslightwala for Akari Therapeutics Plc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.